The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2026

Filed:

Dec. 28, 2022
Applicant:

Neumora Therapeutics, Inc., Watertown, MA (US);

Inventors:

Anne-Marie Beausoleil, Redwood City, CA (US);

Ryan Hudson, Weston, MA (US);

Assignee:

Neumora Therapeutics, Inc., Watertown, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A61K 31/501 (2006.01); A61K 31/55 (2006.01); C07D 403/12 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/501 (2013.01); A61K 31/55 (2013.01); C07D 403/12 (2013.01);
Abstract

Compounds are provided for modulating NLRP3 inflammasome generally, or for treating a NLRP3 inflammasome dependent condition more specifically, by contacting the NLRP3 inflammasome or administering to a subject in need thereof, respectively, an effective amount of a compound having structure (I): or a pharmaceutically acceptable salt, isomer, hydrate, solvate or isotope thereof, wherein R, R, R, R, R, R, R, R, R, R, and Rare as defined herein. Pharmaceutical compositions containing such compounds, as well as the compounds themselves, are also provided.


Find Patent Forward Citations

Beausoleil, Anne-Marie. (2026). Pyridazine derivatives as modulators of nlrp3 inflammasome and related methods (U.S. Patent No. 12760000). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12760000

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…